Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-31

FDA Approved: CHILDRENS XYZAL ALLERGY — Original Application (Chattem, Inc.)

View source ↗

Summary

FDA approved the original application for CHILDRENS XYZAL ALLERGY (levocetirizine dihydrochloride) by Chattem, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for CHILDRENS XYZAL ALLERGY (LEVOCETIRIZINE DIHYDROCHLORIDE)